Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dl-asparagine Hydrate
2. 3130-87-8
3. 69833-18-7
4. 2,4-diamino-4-oxobutanoic Acid Hydrate
5. 2,4-diamino-4-oxobutanoic Acid;hydrate
6. D-asparaginemonohydrate
7. H-dl-asn-oh
8. Dl-aspartic Acid 4-amide
9. Mfcd00151039
10. Dl-asparagine, Monohydrate
11. Asparagine, Monohydrate(9ci)
12. L-asparagine-[amide-15n] Monohydrate
13. 204451-47-8
14. D,l-asn.h2o
15. Schembl50254
16. Asparagine, D-l-, Monohydrate
17. L-asparagine-4-13c Monohydrate
18. Bcp26438
19. 2,4-diamino-4-oxobutanoicacidhydrate
20. Akos016001349
21. (+/-)-2-aminosuccinic Acid 4-amide
22. Ac-24125
23. As-12270
24. Db-015365
25. Db-048007
26. Am20090442
27. Cs-0188414
28. Dl-asparagine Monohydrate, >=99.0% (nt)
29. Ft-0609962
30. Ft-0624454
31. Ft-0625440
32. Ft-0627707
33. En300-71864
34. A-9020
35. L-asparagine Hydrate Pound>>l(+)-asparagine Monohydrate
| Molecular Weight | 150.13 g/mol |
|---|---|
| Molecular Formula | C4H10N2O4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 150.06405680 g/mol |
| Monoisotopic Mass | 150.06405680 g/mol |
| Topological Polar Surface Area | 107 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 134 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
DATA COMPILATION #PharmaFlow
Market Place
ABOUT THIS PAGE
77
PharmaCompass offers a list of L-Asparagine Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Asparagine Monohydrate manufacturer or L-Asparagine Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Asparagine Monohydrate manufacturer or L-Asparagine Monohydrate supplier.
PharmaCompass also assists you with knowing the L-Asparagine Monohydrate API Price utilized in the formulation of products. L-Asparagine Monohydrate API Price is not always fixed or binding as the L-Asparagine Monohydrate Price is obtained through a variety of data sources. The L-Asparagine Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A ANW-27079 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of ANW-27079, including repackagers and relabelers. The FDA regulates ANW-27079 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. ANW-27079 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A ANW-27079 supplier is an individual or a company that provides ANW-27079 active pharmaceutical ingredient (API) or ANW-27079 finished formulations upon request. The ANW-27079 suppliers may include ANW-27079 API manufacturers, exporters, distributors and traders.
click here to find a list of ANW-27079 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A ANW-27079 DMF (Drug Master File) is a document detailing the whole manufacturing process of ANW-27079 active pharmaceutical ingredient (API) in detail. Different forms of ANW-27079 DMFs exist exist since differing nations have different regulations, such as ANW-27079 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A ANW-27079 DMF submitted to regulatory agencies in the US is known as a USDMF. ANW-27079 USDMF includes data on ANW-27079's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The ANW-27079 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of ANW-27079 suppliers with USDMF on PharmaCompass.
ANW-27079 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of ANW-27079 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right ANW-27079 GMP manufacturer or ANW-27079 GMP API supplier for your needs.
A ANW-27079 CoA (Certificate of Analysis) is a formal document that attests to ANW-27079's compliance with ANW-27079 specifications and serves as a tool for batch-level quality control.
ANW-27079 CoA mostly includes findings from lab analyses of a specific batch. For each ANW-27079 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
ANW-27079 may be tested according to a variety of international standards, such as European Pharmacopoeia (ANW-27079 EP), ANW-27079 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (ANW-27079 USP).
